These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25362251)

  • 21. Ropinirole (Requip) for restless legs syndrome.
    Obstet Gynecol; 2006 Jan; 107(1):176-8. PubMed ID: 16394057
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical experience with pramipexole in the treatment of restless legs syndrome.
    Merlino G; Serafini A; Robiony F; Valente M; Gigli GL
    Expert Opin Drug Metab Toxicol; 2008 Feb; 4(2):225-35. PubMed ID: 18248314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Piribedil for restless legs syndrome: a pilot study.
    Evidente VG
    Mov Disord; 2001 May; 16(3):579-81. PubMed ID: 11391766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Restless legs: do they keep you awake?
    Hutchison K; Cuevas R; Jankowiak J
    Neurology; 2004 Dec; 63(12):E21-2. PubMed ID: 15623673
    [No Abstract]   [Full Text] [Related]  

  • 25. Restless legs syndrome (RLS) augmentation associated with dopamine agonist and levodopa usage in a community sample.
    Allen RP; Ondo WG; Ball E; Calloway MO; Manjunath R; Higbie RL; Lee MR; Nisbet PA
    Sleep Med; 2011 May; 12(5):431-9. PubMed ID: 21493132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Impulse control disorder induced by the use of dopamine agonists].
    Weber WE; Nijssen PC
    Ned Tijdschr Geneeskd; 2009 Jan; 153(3):80-1. PubMed ID: 19235343
    [No Abstract]   [Full Text] [Related]  

  • 27. Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs.
    Moore TJ; Glenmullen J; Mattison DR
    JAMA Intern Med; 2014 Dec; 174(12):1930-3. PubMed ID: 25329919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pramipexole: new indication. Restless legs: still no satisfactory drug treatment.
    Prescrire Int; 2007 Feb; 16(87):12. PubMed ID: 17323517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Another dopamine agonist for treatment of restless legs syndrome.
    Earley CJ
    Lancet Neurol; 2011 Aug; 10(8):675-7. PubMed ID: 21705274
    [No Abstract]   [Full Text] [Related]  

  • 30. Ropinirole in a child with attention-deficit hyperactivity disorder and restless legs syndrome.
    Konofal E; Arnulf I; Lecendreux M; Mouren MC
    Pediatr Neurol; 2005 May; 32(5):350-1. PubMed ID: 15866437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Restless leg syndrome, dopamine agonists and sleep attacks.
    Rose AR; Antic NA; McEvoy RD
    Intern Med J; 2008 Nov; 38(11):872-3. PubMed ID: 19120542
    [No Abstract]   [Full Text] [Related]  

  • 32. Restless legs syndrome: symptoms, management and new developments.
    Hyman N
    Br J Hosp Med (Lond); 2008 Mar; 69(3):147-50. PubMed ID: 18422218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of painful sensory symptoms in restless legs syndrome: experience from two clinical trials.
    Hornyak M; Sohr M; Busse M;
    Sleep Med; 2011 Feb; 12(2):186-9. PubMed ID: 21256799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. I've heard the drug I use for restless legs syndrome can cause gambling issues. Should I be concerned?
    Mayo Clin Womens Healthsource; 2007 Dec; 11(12):8. PubMed ID: 17994003
    [No Abstract]   [Full Text] [Related]  

  • 35. Recurrence of cluster headache with pramipexole.
    Ossemann M
    Acta Neurol Belg; 2010 Sep; 110(3):279-80. PubMed ID: 21114140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of pramipexole in restless legs syndrome.
    Kruszewski SP; Shane J
    Neurology; 2007 May; 68(19):1641; author reply 1641-2. PubMed ID: 17485661
    [No Abstract]   [Full Text] [Related]  

  • 37. Ropinirole: new indication. Restless legs: disproportionate adverse effects.
    Prescrire Int; 2006 Oct; 15(85):173-6. PubMed ID: 17128523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The long-term effects of the dopamine agonist pramipexole in a proposed restless legs syndrome animal model.
    Luo F; Li C; Ondo WG; Xu P; Xie W; Le W
    Sleep Med; 2011 Jan; 12(1):41-6. PubMed ID: 21044864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopaminergic treatment of restless legs and rebound phenomenon.
    Guilleminault C; Cetel M; Philip P
    Neurology; 1993 Feb; 43(2):445. PubMed ID: 8094897
    [No Abstract]   [Full Text] [Related]  

  • 40. Propranolol in the treatment of restless legs syndrome induced by imipramine withdrawal.
    Ginsberg HN
    Am J Psychiatry; 1986 Jul; 143(7):938. PubMed ID: 3717447
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.